Appeals court blocks launch of generic Aciphex

07/22/2008 | Bloomberg1

The U.S. Court of Appeals for the Federal Circuit rejected an appeal from Dr. Reddy's Laboratories and Teva Pharmaceutical Industries that challenged Eisai's patent for Aciphex, a treatment for stomach ulcer. The decision prohibits the generic-drug firms from making their versions until the patent expires in May 2013.

View Full Article in:

Bloomberg1

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC